Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triplex Vaccine for CMV Prevention in Haploidentical HCT
NCT04060277Phase 2Active, not recruiting
- Sponsor
- City of Hope
- Start
- Nov 2019
- Primary completion
- Jun 2023
- Modality
- Viral Vectors, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Triplex in cytomegalovirus infection (CMV), sponsored by City of Hope. Started Nov 2019; status: active, not recruiting.
02
Drugs
Triplex
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT04060277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04060277.